Detalhe da pesquisa
1.
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants.
Cell
; 186(7): 1432-1447.e17, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001503
2.
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity.
Cell
; 184(15): 4032-4047.e31, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171309
3.
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade.
Cell
; 178(4): 933-948.e14, 2019 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31398344
4.
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.
Cell
; 173(3): 624-633.e8, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656892
5.
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors.
Nat Immunol
; 21(3): 298-308, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066953
6.
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer.
Immunity
; 56(1): 93-106.e6, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574773
7.
Curbing Tregs' (Lack of) Enthusiasm.
Cell
; 169(6): 981-982, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28575677
8.
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.
Cell
; 170(5): 927-938.e20, 2017 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28841418
9.
Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors.
Immunity
; 54(7): 1561-1577.e7, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102100
11.
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.
Cell
; 162(5): 974-86, 2015 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26317466
12.
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
Nature
; 618(7963): 144-150, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165196
13.
Fundamental immune-oncogenicity trade-offs define driver mutation fitness.
Nature
; 606(7912): 172-179, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545680
14.
Anatomic position determines oncogenic specificity in melanoma.
Nature
; 604(7905): 354-361, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35355015
15.
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+ Monocytic Antigen-Presenting Cells in Tumors.
Immunity
; 48(1): 91-106.e6, 2018 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29343444
16.
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.
Cell
; 169(2): 361, 2017 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28388418
17.
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours.
Nature
; 591(7851): 652-658, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588426
18.
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.
Cell
; 164(5): 1073, 2016 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27064190
19.
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity.
Nature
; 579(7797): 130-135, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076273
20.
Targeting T Cell Co-receptors for Cancer Therapy.
Immunity
; 44(5): 1069-78, 2016 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27192570